Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial
Titel:
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial
Auteur:
Margolis, David A Brinson, Cynthia C Smith, Graham H R de Vente, Jerome Hagins, Debbie P Eron, Joseph J Griffith, Sandy K Clair, Marty H St Stevens, Marita C Williams, Peter E Ford, Susan L Stancil, Britt S Bomar, Melinda M Hudson, Krischan J Smith, Kimberly Y Spreen, William R